SalaryGuide
AboutPricingFor Employers

Marketing jobs

2 marketing jobs

Novartis logo
4 months ago

Associate Director, Web Operations - REMOTE

Novartis

USA (Hybrid)Full time$153K/yr – $283K/yr
Mundial Media logo
4 months ago

Associate Director, Ad Operations

Mundial Media

Los Angeles, CA (On-site)Full time

Find marketing roles you could actually win

2 open roles0

Popular searches:

Growth MarketingHead of MarketingSEO ManagerProduct MarketingPaid MediaBrand Manager
Growth MarketingHead of MarketingPerformance MarketingContent StrategySEO ManagerProduct MarketingDemand GenerationBrand ManagerPaid MediaMarketing AnalyticsCRM ManagerSocial Media

Find marketing roles you could actually win

2 open roles0

Popular searches:

Growth MarketingHead of MarketingSEO ManagerProduct MarketingPaid MediaBrand Manager
Growth MarketingHead of MarketingPerformance MarketingContent StrategySEO ManagerProduct MarketingDemand GenerationBrand ManagerPaid MediaMarketing AnalyticsCRM ManagerSocial Media
2 jobs
Novartis logo

Associate Director, Web Operations - REMOTE

Novartis

USA (Hybrid)

$153K/yr - $283K/yrIn-houseFull-timeSenior level5+ years exp.
4 months ago
Mundial Media logo

Associate Director, Ad Operations

Mundial Media

Los Angeles, CA (On-site)

AgencyFull-timeSenior level5+ years exp.
4 months ago
Novartis logo
Novartis

Associate Director, Web Operations - REMOTE

USA (Hybrid)

$153K/yr – $283K/yrSenior Level5+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive end‑to‑end Web Operations delivery and governance for a regulated pharma brand, with CMS leadership and cross‑region team management to enable scalable, compliant website operations.

  • Must-have: Strong CMS expertise and experience leading operations in a regulated environment.
  • Standout: Cross‑regional team leadership and collaboration with Drupal/product teams for roadmap execution.

Job Description

Responsibilities

  • Leadership: Lead end‑to‑end delivery, governance, and day-to-day operations of centralized Web Operations services, ensuring effective planning, execution, stakeholder engagement, and communication to meet timelines, cost, quality standards, and compliance requirements.
  • Team Leadership: Build, mobilize, and manage cross‑functional teams across regions, aligning resources, roles, and responsibilities to enable consistent delivery and a high‑performing collaborative operating model.
  • Functional Leadership: Lead and develop Web Operations talent across locations, reinforcing Novartis' values, strengthening capabilities, and supporting team performance and engagement.
  • Channel Expertise: Act as a CMS subject‑matter expert, guiding best practices in website management and providing practical direction to maintain high standards, drive continuous improvement, and support innovation in web operations
  • Stakeholder Management: Serve as the primary point of contact for business partners, translating requirements into effective solutions and managing execution, risks, and issues to ensure timely delivery of services and outcomes.
  • Product Collaboration: Partner with the Drupal platform product team and IT stakeholders to support roadmap execution, enable scaled operations for new features, and ensure compliant content deployment.
  • Automation & Efficiency: Identify and implement automation and process improvements to reduce manual effort, improve productivity, and support new launches without increasing spend.
  • Continuous Improvement: Champion standardized processes, operational best practices, and continuous improvement initiatives across Web Operations.
  • Performance & Compliance: Establish and monitor operational metrics and benchmarks, ensuring performance targets are met, while maintaining regulatory and compliance processes.
  • Demand & Financial Management: Manage demand, priorities, and budgets, providing oversight of productivity, operating costs, and quality performance to support Web Operations’ overall delivery objectives.

Requirements

  • 5+ years of experience in commercial design, marketing, or program management within a creative/advertising agency, consulting firm, in‑house agency, or marketing organization, including leading resources and teams in complex, matrixed environments.
  • Experience leading Commercial and/or Marketing Operations within the pharmaceutical or another regulated industry, with the ability to translate operational best practices into effective commercial execution.
  • Strong CMS expertise, with hands‑on experience managing and optimizing content workflows.
  • Solid understanding of web technologies, including responsive design principles, accessibility standards, design systems, and SEO best practices.
  • Experience leveraging web analytics (e.g., Google Analytics) to measure performance, generate insights, and continuously improve website effectiveness.
  • Demonstrated ability to drive operational efficiency, including experience with automation tools and techniques to streamline workflows and improve productivity.
  • Strong communication, presentation, and program management skills, with a track record of delivering results, managing priorities, and maintaining accountability through operational and financial metrics.

Preferred

  • Drupal experience strongly preferred.

Benefits

  • US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits.
  • employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.
Novartis logo

Novartis

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Founded in 1996
Münchenstein, Basel-Country, CHE
82K employees (4,325 in marketing)
www.novartis.com

Traffic Signals

Monthly Visitors
1.1M
Monthly Google Ads Budget
$51.8K
Traffic Source Mix
Search
49.7%
Direct
34.2%
Referral
9.6%
Social
5.5%
Paid
0.9%

Headcount Trend

Current headcount: ~82.6K

Marketing Team

Marketing Team Size
3,475 (4% of company)
Median Career Experience
19 years
Median Tenure
4.9 years
Marketing Roles Posted (Last 30 Days)
8

People

Founders / CEO

Vas Narasimhan
Vas Narasimhan
Chief Executive Officer
At the company for 21 years 4 months

HR / Recruitment

Nicholas Cattafi
Nicholas Cattafi
Talent Acquisition Business Partner - Global Functions
At the company for 11 months
Akash George
Senior Talent Acquisition Business Partner
At the company for 3 years 1 month

Marketing Leadership

Sarita T. Finnie
Sarita T. Finnie
Vice President, Marketing - Cardiovascular
At the company for 6 months
Matt Sabino
Matt Sabino
Vice President, Marketing Immunology
At the company for 24 years 9 months
Weina Wang
Weina Wang
VP, Marketing Strategy, Radioligand Therapy, US Oncology
At the company for 9 years 2 months
Aliah Davis-McHenry
Aliah Davis-McHenry
Global Head (VP), Corporate Marketing
At the company for 2 years

Funding

Total Funding
$2.5B
Last Raise
$2.5B
Post IPO Debt, 2 years ago

Funding History

  • Jun 2024
    Post IPO Debt • $2.5B
  • Feb 2018
    Grant • $6.5M

Recent News

Novartis-Beschäftigte protestieren gegen Stellenabbau
Dec 12, 2025 • syna.ch
Petition: Keine Entlassungen bei Novartis!
Dec 5, 2025 • unia.ch
Novartis baut 550 Jobs ab – Tabletten-Produktion gestoppt
Nov 26, 2025 • Blick
«Trifft uns hart»: Nach dem Novartis-Schock herrschen in Stein Angst und Wut
Nov 26, 2025 • Watson
Hammerschlag Novartis-Abbau: Wie schlimm wird’s?
Nov 26, 2025 • Inside Paradeplatz
Novartis streicht 550 Stellen in Stein AG
Nov 25, 2025 • Schweizer Radio und Fernsehen
Novartis baut im Aargau 550 Stellen ab – «völlig unabhängig» vom US-Ausbau
Nov 25, 2025 • Tages-Anzeiger
550 Festangestellte und 100 Temporäre von Novartis bangen um ihre Jobs
Nov 25, 2025 • workzeitung.ch
«Absurde Industriepolitik fürs Ausland»: Wermuth tobt wegen Novartis-Entlassungen
Nov 25, 2025 • Watson
550 Jobs fallen weg: Hat Novartis ihr Wort gebrochen?
Nov 25, 2025 • Blick
Novartis streicht 550 Stellen. Es ist das vierte grosse Abbauprogramm in nur sieben Jahren
Nov 25, 2025 • Neue Zürcher Zeitung
Novartis stellt am Investorentag weiteres Wachstum in Aussicht - Aktie steigt
Nov 20, 2025 • Cash
Höhere Preise für Medikamente: Das Vorgehen von Novartis kommt einer Erpressung gleich
Nov 20, 2025 • Finanz und Wirtschaft
So will Novartis in der Schweiz die Medikamenten­preise erhöhen
Nov 20, 2025 • Tages-Anzeiger
Novartis stellt am Investorentag weiteres Wachstum in Aussicht
Nov 20, 2025 • Handelszeitung
Novartis baut neues Produktions­zentrum in North Carolina
Nov 19, 2025 • Tages-Anzeiger
Novartis baut Mega-Fabrik in den USA – 700 neue Jobs
Nov 19, 2025 • Blick
Novartis produziert künftig in North Carolina im grossen Stil
Nov 19, 2025 • Cash
Einschätzung: Novartis testet erfolgreich neuartiges Malariamittel
Nov 13, 2025 • Finanz und Wirtschaft
Novartis erzielt Forschungserfolg in Malaria-Bekämpfung
Nov 12, 2025 • Cash
Novartis reisst Lücke in die Rheinfront – Ersatz ist nicht in Sicht
Nov 12, 2025 • bz Basel
Novartis eröffnet Produktion im kalifornischen Carlsbad
Nov 10, 2025 • Cash
Novartis-Aktie: Kurssturz übertrieben oder Einstiegssignal?
Nov 6, 2025 • Cash
FuW-Ersteinschätzung zu den Quartalszahlen: Novartis’ Erfolgsserie nimmt ein Ende
Oct 28, 2025 • Finanz und Wirtschaft
Verunsicherte Anleger: Novartis-Aktie taucht nach Quartalszahlen
Oct 28, 2025 • Neue Zürcher Zeitung
Novartis stellt trotz Generika-Delle weiteres Wachstum in Aussicht
Oct 28, 2025 • Cash
Novartis glänzt mit Quartalszahlen – Gewinn pro Aktie +29 %
Oct 28, 2025 • 20 Minuten
Zahlen des Pharma-Riesen: Novartis wächst weiter, aber das Tempo lässt nach
Oct 28, 2025 • Tages-Anzeiger
Novartis’ Megadeal zeigt, warum Big Pharma ständig zukaufen muss
Oct 27, 2025 • Tages-Anzeiger
Novartis kündigt grösste Übernahme unter CEO Vas Narasimhan an
Oct 27, 2025 • Finanz und Wirtschaft
Novartis kauft ein Biotech-Unternehmen für 12 Mia. US-Dollar
Oct 27, 2025 • Schweizer Radio und Fernsehen
Novartis wagt grösste Übernahme seit zehn Jahren – neue Hoffnung für RNA-Therapien
Oct 27, 2025 • Neue Zürcher Zeitung
Novartis stärkt mit grösstem Zukauf seit 2014 das Geschäft mit Muskelkrankheiten - Anleger reagieren verhalten
Oct 27, 2025 • Cash
Novartis plant Milliardenübernahme in USA
Oct 26, 2025 • Blick
Avidity Biosciences - Novartis will US-Biotech-Firma für 12 Milliarden Dollar kaufen
Oct 26, 2025 • Schweizer Radio und Fernsehen
Novartis erreicht Fortschritte bei Schuppenflechtemittel
Oct 22, 2025 • Finanz und Wirtschaft
Novartis erhält Freigabe für Übernahmeangebot an Tourmaline Bio
Oct 22, 2025 • Cash
Novartis und Roche erzielen bei Scemblix und Gazyva Zulassungerfolge in der EU
Oct 17, 2025 • Finanz und Wirtschaft
Novartis-Mittel Kisqali wirkt auch Jahre nach Therapie gegen Krebsrückfälle
Oct 17, 2025 • Cash
Mittagsführung: NOVARTIS CAMPUS
Oct 17, 2025 • BaselLive
Vontobel stuft Novartis-Aktie neu mit «Hold» ein – Das sind die Gründe
Oct 15, 2025 • Cash
Novartis ernennt neuen Deutschland-Chef
Oct 7, 2025 • Cash
Rhapsido: Novartis erhält FDA-Zulassung für Nesselsuchtmittel
Oct 1, 2025 • Finanz und Wirtschaft
Novartis gibt Trump nach und verbilligt eines seiner Bestseller-Medikamente in den USA
Sep 30, 2025 • Tages-Anzeiger
Direct-to-Patient-Plattform: Novartis startet Direktvertrieb für Top-Medikament Cosentyx in den USA
Sep 29, 2025 • Finanz und Wirtschaft
Novartis will seinen Kassenschlager Cosentyx künftig direkt vermarkten
Sep 29, 2025 • Cash
U.S. Pharma Tariff a 'Significant Concern' to Singapore, Says Top Official
Sep 29, 2025 • MarketScreener
Pharma's Direct-To-Patient Wave Hits Novartis Next
Sep 29, 2025 • Benzinga.com
Novartis announces commencement of tender offer to acquire Tourmaline Bio
Sep 29, 2025 • MarketScreener
Novartis to Launch Direct-to-Patient Platform for Cosentyx in U.S.
Sep 29, 2025 • MarketScreener
REGENXBIO Announces Presentation at the World Muscle Society
Sep 29, 2025 • PR Newswire
Novartis announces commencement of tender offer to acquire Tourmaline Bio
Sep 29, 2025 • MarketScreener
dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management
Sep 29, 2025 • PharmiWeb
Novartis to Launch US Direct-to-Patient Platform for Cosentyx
Sep 29, 2025 • MarketScreener
Dow Jones Top Company Headlines at 1 PM ET: Electronic Arts Goes Private for $55 Billion in Largest LBO Ever | Comcast ...
Sep 29, 2025 • Morningstar.com
United States Cancer Therapeutics Market to Hit $491.6 Billion by 2032, Driven by Precision and Immunotherapy Advances
Sep 29, 2025 • EIN Presswire
Key facts: Novartis will invest $23 billion to build and expand 10 U.S. facilities over five years, including six new plants and an expanded San Diego site, creating over 1,000 jobs.
Sep 27, 2025 • TradingView
US-Zollpolitik - Trump kündigt 100-Prozent-Pharmazölle an – Novartis optimistisch
Sep 26, 2025 • Schweizer Radio und Fernsehen
Novartis erwartet keine Auswirkungen durch US-Zölle
Sep 26, 2025 • Cash
Trump slaps 100 per cent tariff on imported drugs
Sep 26, 2025 • City A.M.
European pharma shares drop after Trump threatens more tariffs
Sep 26, 2025 • Investing.com
The American Cancer Society and National Football League's (NFL) Crucial Catch Initiative Works to Improve Cancer Screening Rates
Sep 26, 2025 • Morningstar.com
Spherix Global Insights Highlights Patient Influence in Shaping PNH Treatment Choices
Sep 26, 2025 • Spherix Global Insights
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
Sep 26, 2025 • Amneal Pharmaceuticals LLC
Trump announces 100% tariffs on pharmaceuticals unless drug makers are building U.S. factories
Sep 26, 2025 • Morningstar.com
Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
Sep 26, 2025 • MarketScreener
Global drugmakers rush to boost US presence as tariff threat looms
Sep 26, 2025 • Reuters
The American Cancer Society and National Football League's (NFL) Crucial Catch Initiative Works to Improve Cancer Screening Rates
Sep 26, 2025 • PR Newswire
Novartis sieht Wirksamkeit von MS-Mittel durch neue Daten untermauert
Sep 24, 2025 • Cash
Novartis says new data further support benefits of Kesimpta
Sep 24, 2025 • MarketScreener
Novartis' Kesimpta achieves new positive results in multiple sclerosis
Sep 24, 2025 • MarketScreener
Novartis Announces New Data from Two Kesimpta®? Studies in Relapsing Multiple Sclerosis
Sep 24, 2025 • MarketScreener
New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
Sep 24, 2025 • Morningstar.com
AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research
Sep 23, 2025 • PR Newswire
AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86 Billion by 2035, Growing at a CAGR 21% | Vantage Market Research
Sep 23, 2025 • PR Newswire UK
Dysmenorrhea Treatment Market Size, Forecast, Growth, Analysis, Industry Trends & Key Players 2024-2032
Sep 23, 2025 • EIN Presswire
US FDA declines to approve higher dose of Biogen’s genetic disorder drug
Sep 23, 2025 • Investing.com
Cyclosporine Market Size to Hit USD 9.44 Billion by 2032, Driven by Rising Organ Transplants and Expanding Therapeutic Applications | S&S Insider
Sep 23, 2025 • SNS Insider pvt ltd
Novartis-CEO: «Medikamentenpreise in der Schweiz viel zu tief» – «Gegenteil ist der Fall»
Sep 22, 2025 • Watson
Roche Targets Top Spot In Weight Loss Drug Market
Sep 22, 2025 • Benzinga.com
Novartis Looking for Constructive Ways to Bring Down Drug Costs in US
Sep 22, 2025 • BioSpace
RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence
Sep 22, 2025 • PR Newswire
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Sep 22, 2025 • Research and Markets
Novartis Builds US Drug Reserves Against Potential Tariffs
Sep 22, 2025 • Benzinga.com
RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence
Sep 22, 2025 • PR Newswire UK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WOW, PRO, TRML, PGRE on Behalf of Shareholders
Sep 22, 2025 • Halper Sadeh LLC
Novartis erzielt aufsehenerregenden Durchbruch in der Krebsforschung
Sep 21, 2025 • SWI swissinfo.ch
Novartis increased its stockpiles of pharmaceuticals in the U.S., Reuters says
Sep 21, 2025 • thefly.com
Swiss Pharma Novartis Mulls Options to Reduce US Drug Prices
Sep 21, 2025 • MarketScreener
Novartis looking into price cut proposals for U.S., Bloomberg reports
Sep 21, 2025 • thefly.com
«In der Schweiz sind die Medikamentenpreise viel zu tief», sagt der Novartis-Chef
Sep 20, 2025 • Neue Zürcher Zeitung
Schweizer Arzneien-Preise «viel zu tief»: Novartis will Unterschied zu den USA eliminieren
Sep 20, 2025 • Watson
Novartis: Preissenkungen in den USA werden geprüft
Sep 20, 2025 • 20 Minuten
Novartis-Chef will Medikamente in den USA vergünstigen
Sep 20, 2025 • Blick
«Schweizer zahlen viel zu wenig»: Novartis-CEO für teurere Medikamente
Sep 20, 2025 • Basler Zeitung
Novartis Chief Eyes Ways To End Higher US Drug Prices: Media
Sep 20, 2025 • International Business Times
Novartis has stockpiles to withstand potential Trump tariffs, CEO says
Sep 20, 2025 • Yahoo Finance
Novartis has stockpiles to withstand potential Trump tariffs, CEO says
Sep 20, 2025 • MarketScreener
Novartis has stockpiles to withstand potential Trump tariffs, CEO says
Sep 20, 2025 • Investing.com
Polish healthtech startup Doctor.One raises €4M seed round to expand across Europe
Sep 19, 2025 • ain.ua